[Federal Register Volume 68, Number 52 (Tuesday, March 18, 2003)]
[Notices]
[Pages 12918-12919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-6435]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose

[[Page 12919]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the contract proposals, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Novel Technologies for Noninvasive Detection, Diagnosis and 
Treatment of Cancer.
    Date: April 21, 2003.
    Time: 8 a.m. to 7 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, 6130 Executive Plaza North, 
Executive Blvd., Conference Room H, Rockville, MD 20852.
    Contact Person: Sherwood Githens, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, National Cancer 
Institute, National Institutes of Health, 6116 Executive Boulevard, 
Room 8068, Bethesda, MD 20892, (301) 435-1822.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: March 12, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-6435 Filed 3-17-03; 8:45 am]
BILLING CODE 4140-01-M